$TBPH Theravance Biopharma, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Theravance Biopharma, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Theravance Biopharma, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Theravance Biopharma, Inc. for free.

CIK Number: 0001583107
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: TBPH
Company Address: UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN KY1-1104

Theravance Biopharma, Inc. operates as a biopharmaceutical company, which focuses on the discovery, development and commercialization of small molecule medicines. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand and neprilysin. The company was founded on July 2013 and is headquartered in George Town, Cayman Islands.

Market Capitalization: $1.64B
Prev close: $30.60
Average Daily Volume: 346,635
Days Low: $30.63
Year Low: $13.59
Year High: $38.92

Theravance Biopharma, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
GALA RENEE DSVP, Chief Financial Officer207,7946,358,496shares bought: 99,000 / shares sold: -42,736 STRONG BUYNov 22 20172 months ago
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc141,4964,329,778shares bought: 99,000 / shares sold: -79,012 BUYNov 22 20172 months ago
HEGDE SHARATHCHANDRA SSVP, Research154,9604,741,776shares bought: 114,000 / shares sold: -31,205 STRONG BUYNov 22 20172 months ago
PASQUALONE FRANKSVP, Chief Comm Ops Officer207,3606,345,216shares bought: 103,000 / shares sold: -26,222 STRONG BUYNov 22 20172 months ago
PITZER KENNETH RSVP, Prod Strat & Comm Plng147,3064,507,564shares bought: 114,000 / shares sold: -30,255 STRONG BUYNov 22 20172 months ago
Shafer Bradford JEVP, Gen. Counsel, Secretary127,2483,893,789shares bought: 124,000 / shares sold: -136,322 SELLNov 22 20172 months ago
WORBOYS PHILIP DSVP, Translational Science159,1294,869,347shares bought: 114,000 / shares sold: -33,218 STRONG BUYNov 22 20172 months ago

View all Theravance Biopharma, Inc. insiders.

Theravance Biopharma, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Nov 22 2017TBPHTheravance Biophar ...WORBOYS PHILIP DSVP, Translational ...Payment of ExerciseF28.585,503157,276159,129164.6 K to 159.1 K (-3.34 %)
Nov 22 2017TBPHTheravance Biophar ...Shafer Bradford JEVP, Gen. Counsel, ...Payment of ExerciseF28.587,079202,318127,248134.3 K to 127.2 K (-5.27 %)
Nov 22 2017TBPHTheravance Biophar ...PITZER KENNETH RSVP, Prod Strat & C ...Payment of ExerciseF28.585,014143,300147,306152.3 K to 147.3 K (-3.29 %)
Nov 22 2017TBPHTheravance Biophar ...PASQUALONE FRANKSVP, Chief Comm Ops ...Payment of ExerciseF28.585,820166,336207,360213.2 K to 207.4 K (-2.73 %)
Nov 22 2017TBPHTheravance Biophar ...HEGDE SHARATHCHANDRA SSVP, ResearchPayment of ExerciseF28.585,177147,959154,960160.1 K to 155 K (-3.23 %)
Nov 22 2017TBPHTheravance Biophar ...HAUMANN BRETT KSVP Clin Dev & Chie ...Payment of ExerciseF28.587,846224,239141,496149.3 K to 141.5 K (-5.25 %)
Nov 22 2017TBPHTheravance Biophar ...GALA RENEE DSVP, Chief Financia ...Payment of ExerciseF28.586,753193,001207,794214.5 K to 207.8 K (-3.15 %)
Sep 08 2017TBPHTheravance Biophar ...Shafer Bradford JEVP, Gen. Counsel, ...SellS30.7714,670451,350134,327149 K to 134.3 K (-9.85 %)
Aug 23 2017TBPHTheravance Biophar ...PASQUALONE FRANKSVP, Chief Comm Ops ...BuyP26.344,000105,359213,180209.2 K to 213.2 K (+1.91 %)
Aug 22 2017TBPHTheravance Biophar ...WORBOYS PHILIP DSVP, Translational ...Payment of ExerciseF27.405,502150,755164,632170.1 K to 164.6 K (-3.23 %)
Aug 22 2017TBPHTheravance Biophar ...Shafer Bradford JEVP, Gen. Counsel, ...Payment of ExerciseF27.407,079193,965148,997156.1 K to 149 K (-4.54 %)
Aug 22 2017TBPHTheravance Biophar ...PITZER KENNETH RSVP, Prod Strat & C ...Payment of ExerciseF27.405,013137,356152,320157.3 K to 152.3 K (-3.19 %)
Aug 22 2017TBPHTheravance Biophar ...PASQUALONE FRANKSVP, Chief Comm Ops ...Payment of ExerciseF27.405,820159,468209,180215 K to 209.2 K (-2.71 %)
Aug 22 2017TBPHTheravance Biophar ...HEGDE SHARATHCHANDRA SSVP, ResearchPayment of ExerciseF27.405,176141,822160,137165.3 K to 160.1 K (-3.13 %)
Aug 22 2017TBPHTheravance Biophar ...HAUMANN BRETT KSVP Clin Dev & Chie ...Payment of ExerciseF27.407,064193,554149,342156.4 K to 149.3 K (-4.52 %)

View all Theravance Biopharma, Inc. insider transactions.